June Bray serves as Executive at BioXcel Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, June Bray has executed 2 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jan 9, 2026 involved receiving (via award) 17,000 shares valued at $0.
June Bray currently holds 17,000 shares of BioXcel Therapeutics, Inc. (BTAI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, June Bray has been a net neutral trader of BTAI stock. They have purchased $0 and sold $0 worth of shares.
June Bray's most recent insider trade was on Jan 9, 2026, when they sold 17,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |